Insights
Insights From Our Experts
Articles
Critical Success Factors for Launching Products with Orphan Drug Designation
Posted by
Siddharth Agrawal , Andrew Therrien, PhD , Dianna Cohen on February 21, 20232/21/23
The Orphan Drug Act (ODA) was passed in 1983 to financially incentivize pharmaceutical companies to develop drugs for rare diseases or conditions, defined as a disease or condition that affects less than 200,000 people in the…
How Generative AI and Synthetic Content Will Revolutionize Healthcare
The current state of technology is rapidly evolving. Areas such as Artificial Intelligence (AI) have made tremendous strides in generative models and synthetic content, such as ChatGPT, which was recently released. AI has the potential to…
Filling Evidence Gaps Through Consensus: Revisiting the Delphi Technique
With the launch of any medical device, companies and healthcare providers must be thoughtful about answering the following questions: Who will benefit from this device? What problem does it address? How does this device fit into…
Optimizing and Accelerating Membership Management Within the Healthcare Industry
The various complexities and ever-changing nature of the pharmaceutical and health care industries create endless intricate processes, datasets and other components for manufacturers to navigate. Properly maintaining a Customer Master can be one of the most…
Bending the “Commercialization Curve” in Large Pharma
If the last few years have taught us anything, it’s that it’s more important than ever to embrace change and new ways to bring therapies to patients. This is especially the case when considering commercialization and…
Account Engagement Excellence: How Advanced Analytics Can Enable Next-Generation Account Segmentation
Account/customer segmentation is a crucial exercise at the beginning of any strategy related to healthcare provider, patient, or payer engagement. Due to the large variety of customers, it is critical to know one’s customers well, from…
Trade & Channel Strategies: Partnership Pavilion Panel
Panel Summary: The challenges of commercialization are abundant. Now more than ever, the right partner and understanding the patient journey are pivotal to commercialization success and ensuring patient access to therapy. During this panel, EVERSANA, EVOKE…
The Expanding Oncology Market Prompts Reevaluation of Field Team Training Procedures and Skill Set to Impact Frontline Success
Since 2015, the oncology pipeline has grown by 75%. Simultaneous to the exponential pipeline growth, the market has become increasingly unpredictable with an abundance of challenges such as unprecedented speed to market, securing patient access and…
Pivot Pros: How EVERSANA Course Corrected When the Market Changed
Traditional commercialization models lack the insights, flexibility and agility to synthesize and react to real-time data. If you needed to quickly pivot your strategy to ensure the success of your therapy in market, would your commercialization…
The New Role of Medical Field Teams and Their Impact on Launch Success
A combination of industry challenges and an influx of complex therapies in the market, have impacted Medical Science Liaisons (MSLs), Clinical Trial Liaisons (CTLs) and Clinical Nurse Educators (CNEs). Susan Giacalone, MSN, BCMAS, MSL-BC, Vice President,…